Evidence map›Paper›PMID 36699893›Full record

ArticleFrontiers in public health2022

An evaluation of an innovative screening program based on risk criteria for early diagnosis of head and neck cancers.

Aitor Zabala, Francisco Javier Martín-Arregui, Jon Sagazola, Francisco Javier Santaolalla, Francisco Santaolalla

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aitor ZabalaOtorhinolaryngology Department, Basurto University Hospital, OSI Bilbao-Basurto, IIS BioBizkaia, Basque Health Service/Osakidetza, Bilbao, Spain.
Francisco Javier Martín-ArreguiOtorhinolaryngology Department, Basurto University Hospital, OSI Bilbao-Basurto, IIS BioBizkaia, Basque Health Service/Osakidetza, Bilbao, Spain.
Jon SagazolaOtorhinolaryngology Department, Basurto University Hospital, OSI Bilbao-Basurto, IIS BioBizkaia, Basque Health Service/Osakidetza, Bilbao, Spain.
Francisco Javier SantaolallaOtorhinolaryngology Department, Basurto University Hospital, OSI Bilbao-Basurto, IIS BioBizkaia, Basque Health Service/Osakidetza, Bilbao, Spain.
Francisco SantaolallaOtorhinolaryngology Department, Basurto University Hospital, OSI Bilbao-Basurto, IIS BioBizkaia, Basque Health Service/Osakidetza, Bilbao, Spain.
University of the Basque Country · ESHospital de Basurto · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Head and neck cancer represents 3% of all cancers and is the cause of 5% of the deaths caused by cancer. The purpose of this study is to evaluate the implementation of a screening program to diagnose the early phase of the head and neck oncological processes. Methods: We have studied 324 asymptomatic patients who had at least one major risk factor (habitual consumption of tobacco or alcohol) or two minor risk factors: family history of head and neck cancer of the upper aerodigestive tract, occupational exposure, poor oral hygiene and history of Human Papillomavirus or chronic inflammatory processes of the aerodigestive tract. Family and personal head and neck oncological medical history, ENT exploration, performance of CT scans or biopsies and program procedures were analyzed. Results: The most usual referral criteria for being sent to a specialist was being a smoker (98.1%). 10.5% reported family histories of head and neck cancer, 9.9% reported occupational exposure, 7.1% were referred due to poor oral hygiene and 5.9% were referred for gastroesophageal reflux disease. Although being asymptomatic was a requirement for inclusion, we verified that, after the anamnesis, 9.6% of the patients had some symptom to which they did not give importance to 119 patients (36.7%) presented a lesion that potentially could become malignant, located in the larynx and hypopharynx (25%) and in the oral cavity and oropharynx (10.8%). Eighteen patients (5.56%) presented more than one lesion. The detection rate of neoplasia was 1.2% and the detection rate of pre-neoplastic lesions was 4.6%. There did exist a statistically significant ratio between the detection of pre-neoplastic lesions and occupational exposure to carcinogenic agents ( Conclusions: The use of this screening program could be a tool for the early diagnosis of malignant head and neck tumors and to foster healthy habits for cancer prevention.

Indexed as

Gastroesophageal RefluxHead and Neck NeoplasmsEarly Detection of CancerHumansRisk FactorsTobacco Productscarcinomahead and neckrisk factorscreeningtobacco

Identifiers

PMID36699893
PMCPMC9868380
OpenAlexW4313826517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.